These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 28893284
1. Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract. Vitali D, Wessels JM, Kaushic C. AIDS Res Ther; 2017 Sep 12; 14(1):39. PubMed ID: 28893284 [Abstract] [Full Text] [Related]
2. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women. Wessels JM, Felker AM, Dupont HA, Kaushic C. Dis Model Mech; 2018 Aug 28; 11(9):. PubMed ID: 30154116 [Abstract] [Full Text] [Related]
3. Influence of common mucosal co-factors on HIV infection in the female genital tract. Ferreira VH, Kafka JK, Kaushic C. Am J Reprod Immunol; 2014 Jun 28; 71(6):543-54. PubMed ID: 24617528 [Abstract] [Full Text] [Related]
4. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment. Kaushic C, Ferreira VH, Kafka JK, Nazli A. Am J Reprod Immunol; 2010 Jun 28; 63(6):566-75. PubMed ID: 20384619 [Abstract] [Full Text] [Related]
5. Understanding mucosal and microbial functionality of the female reproductive tract by metaproteomics: Implications for HIV transmission. Berard AR, Perner M, Mutch S, Farr Zuend C, McQueen P, Burgener AD. Am J Reprod Immunol; 2018 Aug 28; 80(2):e12977. PubMed ID: 29790240 [Abstract] [Full Text] [Related]
6. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R. AIDS; 2007 Mar 12; 21(5):589-98. PubMed ID: 17314521 [Abstract] [Full Text] [Related]
7. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome. Mtshali A, Ngcapu S, Mindel A, Garrett N, Liebenberg L. J Reprod Immunol; 2021 Jun 12; 145():103291. PubMed ID: 33647576 [Abstract] [Full Text] [Related]
8. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women. Munusamy Ponnan S, Thiruvengadam K, Tellapragada C, Ambikan AT, Narayanan A, Kathirvel S, Mathayan M, Shankar J, Rajaraman A, Afshan Amanulla M, Dinesha TR, Poongulali S, Saravanan S, Murugavel KG, Swaminathan S, Velu V, Shacklett B, Neogi U, Hanna LE. Microbiol Spectr; 2021 Oct 31; 9(2):e0047021. PubMed ID: 34704803 [Abstract] [Full Text] [Related]
9. Mechanisms of mucosal immunity at the female reproductive tract involved in defense against HIV infection. Choi MW, Isidoro CA, Gillgrass A. Curr Opin Virol; 2024 Jun 31; 66():101398. PubMed ID: 38484474 [Abstract] [Full Text] [Related]
10. Hormonal influence on HIV-1 transmission in the female genital tract: New insights from systems biology. Dupont HA, Lam J, Woods MW, Zahoor MA, Kaushic C. Am J Reprod Immunol; 2018 Aug 31; 80(2):e13019. PubMed ID: 30014538 [Abstract] [Full Text] [Related]
11. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology. Shannon B, Gajer P, Yi TJ, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, Huibner S, Shahabi K, Ravel J, Kaul R. J Infect Dis; 2017 May 01; 215(9):1366-1375. PubMed ID: 28201724 [Abstract] [Full Text] [Related]
12. How oestrogen or progesterone might change a woman's susceptibility to HIV-1 infection. Mingjia L, Short R. Aust N Z J Obstet Gynaecol; 2002 Nov 01; 42(5):472-5. PubMed ID: 12495087 [Abstract] [Full Text] [Related]
13. Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission. Jewanraj J, Ngcapu S, Liebenberg LJP. Am J Reprod Immunol; 2021 Nov 01; 86(5):e13478. PubMed ID: 34077596 [Abstract] [Full Text] [Related]
14. The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract. Wira CR, Rodriguez-Garcia M, Shen Z, Patel M, Fahey JV. Am J Reprod Immunol; 2014 Aug 01; 72(2):171-81. PubMed ID: 24661500 [Abstract] [Full Text] [Related]
15. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV. Farcasanu M, Kwon DS. Curr HIV/AIDS Rep; 2018 Feb 01; 15(1):30-38. PubMed ID: 29516267 [Abstract] [Full Text] [Related]
16. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Cole AM, Cole AL. Am J Reprod Immunol; 2008 Jan 01; 59(1):27-34. PubMed ID: 18154593 [Abstract] [Full Text] [Related]
17. Genital immunology and HIV susceptibility in young women. Yi TJ, Shannon B, Prodger J, McKinnon L, Kaul R. Am J Reprod Immunol; 2013 Feb 01; 69 Suppl 1():74-9. PubMed ID: 23157424 [Abstract] [Full Text] [Related]
18. The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes. Murphy K, Mitchell CM. J Infect Dis; 2016 Aug 15; 214 Suppl 1(Suppl 1):S29-35. PubMed ID: 27056955 [Abstract] [Full Text] [Related]
19. Vaginal microbiota and its role in HIV transmission and infection. Petrova MI, van den Broek M, Balzarini J, Vanderleyden J, Lebeer S. FEMS Microbiol Rev; 2013 Sep 15; 37(5):762-92. PubMed ID: 23789590 [Abstract] [Full Text] [Related]
20. Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility. Woods MW, Zahoor MA, Dizzell S, Verschoor CP, Kaushic C. Am J Reprod Immunol; 2018 Jan 15; 79(1):. PubMed ID: 29105931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]